Professor Stefan Anker
Charite University Hospital, Berlin (Germany)
Membership:
FESC Member
HFA Member
Follow
Biography
Stefan D. Anker is Professor of (Tissue)Homeostasis in Cardiology & Metabolism at Charité Berlin. He obtained his MD (1993) from Charité Berlin, and his PhD (1998) from Imperial College London. Dr. Anker has authored more than 1,300 articles. He is named Highly Cited Researcher 2015–2023.
Dr. Anker obtained a number of fellowships & grants, and for his work Dr. Anker has won several prizes, including the 2018 Copernicus Prize of German DFG & Polish FNP. Dr. Anker was awarded a Doctor honoris causa (Medical University Wroclaw / POL & Semmelweis University Budapest.
Dr. Anker was Vice President of the ESC (2016-18) and President of the HFA of the ESC (2012-14). He was founding EiC of ESC Heart Failure (2014-22), and of JCSM (since 2010).
Dr. Anker was and is member of >30 international clinical trial steering committees, chairing or co-chairing several currently (incl. FAIR-HF2, RESHAPE-HF2) as well as in the past (incl. EMPEROR-Preserved, FAIR-HF).
Contributor content
Session
Non-steroidal mineralocorticoid receptor antagonists: current role and implementation in the management of patients with heart failure
10 May 2026
Session
Innovative approaches in the management of patients with heart failure with reduced ejection fraction (HFrEF) in the era of guideline-directed medical therapy (GDMT)
10 May 2026
Session
Session
Shunting forward: new insights, mechanisms, and the future of interatrial shunt devices in heart failure
29 August 2025
Session
Session
Session
Interventional therapies in heart failure - from the left heart side to the right and back
12 May 2024
Session
Baroreflex activation therapy in HFrEF patients: international strategies for patient selection and management
12 May 2024
Session
Session
Practical guidance to implement heart failure treatment with SGLT2 inhibitors in the outpatient setting
27 August 2023
